Furthermore, SNAI (SLUG), a well-known biological inhibitor of PUMA and p53 [16], was significantly decreased in P21-overexpressing cells for each GBM line, positioning SNAI as a plausible regulator of P21-mediated PUMA expression (Figure 3B). The gene discussed is TP53; the disease is glioblastoma.